GCH1 Knockout Cell Line (HEK293)

The choice depends on whether you are studying GCH1's role as the rate-limiting enzyme of tetrahydrobiopterin (BH4) biosynthesis in a high-transfection-efficiency mechanistic platform. The Knockout line is the standard tool for asking whether GCH1 is required for de novo BH4 biosynthesis — GCH1 catalyzes the first and rate-limiting step (GTP → 7,8-dihydroneopterin triphosphate), generating BH4 as an essential cofactor for aromatic amino acid hydroxylases (PAH, TH, TPH), nitric oxide synthases (NOS), and alkylglycerol monooxygenase. Overexpression is useful for studying GCH1 gain-of-function effects. For systematic BH4 biology, the EDITGENE GCH1 Knockout in HEK293 is a workhorse mechanistic platform — HEK293 supports systematic structure-function studies. This product complements the parallel GCH1 Knockout in HaCaT (also available); HEK293 is preferred for biochemistry, HaCaT for skin/keratinocyte context. GCH1 dominant-negative mutations cause dopa-responsive dystonia (Segawa syndrome); GCH1 polymorphisms are associated with chronic pain susceptibility (one of the strongest pain GWAS loci). Rescue with wild-type or catalytically-dead GCH1 enables structure-function studies. The knockout is valuable for studying BH4-dependent enzymes and BH4-related therapeutics (sapropterin/Kuvan for PKU).

Primary applications: • BH4 quantification: cellular BH4 and BH2 levels by HPLC or LC-MS in GCH1-null versus rescued cells. • Structure-function studies: HEK293's transfection efficiency supports systematic rescue with wild-type, catalytically-dead, and dominant-negative GCH1 variants. • Dopa-responsive dystonia modeling: rescue with patient-derived dominant-negative GCH1 mutations for genotype-function studies. • Pain GWAS variant studies: rescue with pain-associated GCH1 polymorphisms for pharmacogenomic studies. EDITGENE recommends this HEK293-based model for biochemical GCH1 research; the parallel GCH1 Knockout in HaCaT (also available) is preferred for keratinocyte/skin context.

Yes. GCH1 rescue experiments are well-established for BH4 research: • Construct design: use a codon-modified GCH1 sequence with a small C-terminal tag (FLAG, HA). GCH1 functions as a homodecamer — preserve oligomerization regions. • Catalytically-dead rescue: active site residue mutations abolish GTP cyclohydrolase activity. • Dopa-responsive dystonia rescue: patient-derived dominant-negative GCH1 mutations for disease genotype-function studies. • Functional readout: rescue should restore cellular BH4 levels measured by HPLC. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.